Trump signed an executive order Saturday to ease research restrictions on psychedelic drugs like psilocybin and LSD, aiming to accelerate studies into their potential for treating mental health conditions.

Read more at Read More

By

Leave a Reply

Your email address will not be published. Required fields are marked *